Vaishali Pharma Limited (VAISHALI) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE972X01022
Key metrics
- Market Cap
- ₹105 Cr
- P/E Ratio
- 134.33
- EPS
- 0.06
- Book Value
- 4.98
- P/B Ratio
- 1.61
- ROE
- 1.26%
- ROCE
- 7.64%
- Debt / Equity
- 0.19
- Net Margin
- 0.84%
- Revenue Growth
- 19.71%
- Profit Growth
- 13.7%
- Dividend Yield
- —
- 52W High
- ₹12.70
- 52W Low
- ₹4.75
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2025-03-31.
About Vaishali Pharma Limited
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, antimalarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-viral, anti-epileptic, anti-asthmatic, enzymes, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helminitic. The company also provides formulations, including antibiotics, antibacterial, anti-platelet, laxative, anti-ulcer, enzymes, anti-asthmatic, anti-malarial, anti-cold, anti-allergic, anti-viral, anti-psychotic, anti-fungal, vitamins, topical steroids, corticosteroids, anti-inflammatory, analgesic, anti-pyretic, anti-diabetic, cardiac, and other products. In addition, it offers disposable surgical and casting tape products; herbal products; veterinary products; nutraceutical products; and oncology products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
The full Vaishali Pharma Limited analysis
Create a free account to open the complete VAISHALI deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.